Physician profile
Peter Conrad Ng
NPI 1063412377
$267,711.28
in general payments reported to CMS, 2019-2025
34 companies · $32K in 2025
The $32K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $32K · 2022: $55K · 2023: $53K · 2024: $65K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77K · Consulting Fee: $57K · Travel and Lodging: $8,200 · Food and Beverage: $7,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $76,833.00 |
| Consulting Fee | $56,950.08 |
| Travel and Lodging | $8,200.20 |
| Food and Beverage | $7,468.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $118,183.08 | 2019-2024 | Echelon Flex, Stratafix, Enseal |
| Medtronic, INC. | $116,357.46 | 2021-2025 | Ligasure, Signia, Endo Gia Ultra |
| Ethicon US, LLC | $13,888.78 | 2019-2025 | Echelon Flex, Echelon; Endopath, Enseal X1 |
| Covidien LP | $11,493.01 | 2019-2020 | |
| Ethicon INC. | $2,175.00 | 2021 | |
| Intuitive Surgical, INC. | $1,292.99 | 2019-2023 | Da Vinci Surgical System |
| Teleflex LLC | $1,178.09 | 2020-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Novo Nordisk INC | $590.08 | 2019-2025 | Wegovy |
| Checkpoint Surgical, INC | $392.37 | 2021-2022 | |
| Abbvie INC. | $390.06 | 2019-2025 | |
| Intra-Sana Laboratories | $245.95 | 2021-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Pulmonx Corporation | $217.19 | 2019-2020 | |
| Tela Bio, INC. | $215.14 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $156.42 | 2019-2023 | Tisseel |
| Aimmune Therapeutics, INC. | $144.39 | 2024-2025 | Zenpep |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $125.71 | 2022-2025 | Gattex |
| Lilly USA, LLC | $114.40 | 2023-2025 | Zepbound |
| Acell, INC. | $96.63 | 2019 | |
| Nestle Healthcare Nutrition INC. | $79.24 | 2020-2022 | |
| Davol INC. | $73.79 | 2023 | Phasix Mesh, Arista Ah Flexitip |
| Boston Scientific Corporation | $43.39 | 2025 | Overstitch Endoscopic Suturing System |
| Innocoll Pharmaceuticals Limited | $41.51 | 2021-2022 | |
| Eisai INC. | $33.99 | 2019 | |
| Tricoast Surgical Solutions LLC | $29.08 | 2024 | |
| Ambu INC. | $19.21 | 2022 | |
| Vivus LLC | $19.04 | 2025 | Pancreaze |
| Standard Bariatrics, INC. | $18.78 | 2022 | |
| Endo Pharmaceuticals INC. | $18.40 | 2020 | |
| Becton, Dickinson and Company | $15.51 | 2022 | |
| Currax Pharmaceuticals LLC | $14.13 | 2021 | |
| Hologic Sales and Service, LLC | $13.88 | 2024 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $12.45 | 2022 | |
| Endogastric Solutions, INC | $11.16 | 2022 | |
| Echosens North America, INC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.